Literature DB >> 21286663

Ethanolic extract of Brazilian green propolis sensitizes prostate cancer cells to TRAIL-induced apoptosis.

Ewelina Szliszka1, Grzegorz Zydowicz, Beata Janoszka, Cezary Dobosz, Grazyna Kowalczyk-Ziomek, Wojciech Krol.   

Abstract

Prostate cancer represents an ideal disease for chemopreventive intervention. Propolis possesses immuno-modulatory, anti-tumour and chemopreventive properties. The tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is an important endogenous anti-cancer agent that induces apoptosis selectively in tumour cells. However, some cancer cells are resistant to TRAIL-mediated apoptosis. Naturally occurring phenolic and polyphenolic compounds sensitize TRAIL-resistant cancer cells and augment the apoptotic activity of TRAIL. The ethanolic extract of Brazilian green propolis (EEP) is rich in phenolic components. Our in vitro results indicate the potential targets in the TRAIL-induced apoptotic pathway for the cancer chemopreventive activity of Brazilian propolis. We examined the cytotoxic and apoptotic effects of Brazilian EEP and its bioactive components in combination with TRAIL on LNCaP prostate cancer cells. The chemical composition of Brazilian green propolis was determined by high performance liquid chromatography-diode array detection. The cytotoxicity was measured by 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl-tetrazolium and lactate dehydrogenase assays. Apoptosis was detected using annexin V-FITC by flow cytometry and fluorescence microscopy. The mitochondrial membrane potential (∆Ψm) was evaluated using DePsipher staining by fluorescence microscopy. Flow cytometry was used to analyse death receptor (TRAIL-R1 and TRAIL-R2) expression in LNCaP cells. The inhibition of nuclear factor-κB (NF-κB) (p65) activation in cancer cells was confirmed by the ELISA-based TransAM NF-κB kit. The LNCaP cells were shown to be resistant to TRAIL-induced apoptosis. Our study demonstrates that EEP sensitizes TRAIL-resistant prostate cancer cells. The main phenolic components detected in Brazilian green propolis are artepillin C, quercetin, kaempferol and p-coumaric acid. Brazilian propolis and its bioactive components markedly augmented TRAIL-mediated apoptosis and cytotoxicity in prostate cancer cells. Brazilian EEP enhanced the expression of TRAIL-R2 and the activity of NF-κB in LNCaP cells. The co-treatment of prostate cancer cells with 100 ng/ml TRAIL and 50 µg/ml EEP increased the percentage of apoptotic cells to 65.8 ± 1.2% and caused a significant disruption of ∆Ψm in LNCaP cells. We show that Brazilian EEP helped cells overcome TRAIL resistance by engaging both intrinsic and extrinsic apoptotic pathways and regulating NF-κB activity. The data demonstrate the important role of Brazilian green propolis and its bioactive compounds in prostate cancer chemoprevention through the enhancement of TRAIL-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21286663     DOI: 10.3892/ijo.2011.930

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  41 in total

Review 1.  NutriTRAILomics in prostate cancer: time to have two strings to one's bow.

Authors:  Ammad Ahmad Farooqi; Aamir Rana; Asma M Riaz; Ammara Khan; Muhammad Ali; Sara Javed; Shahzeray Mukhtar; Sehrish Minhaj; Javeria Rafique Rao; Javairia Rajpoot; Rafia Amber; Fiza Asif Javed; Reema Khanum; Shahzad Bhatti
Journal:  Mol Biol Rep       Date:  2011-12-06       Impact factor: 2.316

2.  Protective effects of Brazilian propolis supplementation on capillary regression in the soleus muscle of hindlimb-unloaded rats.

Authors:  Masayuki Tanaka; Miho Kanazashi; Noriaki Maeshige; Hiroyo Kondo; Akihiko Ishihara; Hidemi Fujino
Journal:  J Physiol Sci       Date:  2018-09-19       Impact factor: 2.781

Review 3.  TRAIL-mediated signaling in prostate, bladder and renal cancer.

Authors:  Christina Voelkel-Johnson
Journal:  Nat Rev Urol       Date:  2011-06-14       Impact factor: 14.432

Review 4.  Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.

Authors:  Xiaoyun Dai; Jingwen Zhang; Frank Arfuso; Arunachalam Chinnathambi; M E Zayed; Sulaiman Ali Alharbi; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-07

5.  Jolkinolide B from Euphorbia fischeriana Steud induces apoptosis in human leukemic U937 cells through PI3K/Akt and XIAP pathways.

Authors:  Jia-He Wang; Yi-Jun Zhou; Xue Bai; Ping He
Journal:  Mol Cells       Date:  2011-11-11       Impact factor: 5.034

6.  Cytotoxic and apoptotic activities of Amorphophallus campanulatus (Roxb.) Bl. tuber extracts against human colon carcinoma cell line HCT-15.

Authors:  P N Ansil; P J Wills; R Varun; M S Latha
Journal:  Saudi J Biol Sci       Date:  2014-01-28       Impact factor: 4.219

7.  A1E inhibits proliferation and induces apoptosis in NCI-H460 lung cancer cells via extrinsic and intrinsic pathways.

Authors:  Yesol Bak; Sunyoung Ham; O Baatartsogt; Seung Hyun Jung; Kang-Duk Choi; Tae-Young Han; Il-Young Han; Do-Young Yoon
Journal:  Mol Biol Rep       Date:  2013-05-07       Impact factor: 2.316

8.  20(s)-ginsenoside Rg3 promotes apoptosis in human ovarian cancer HO-8910 cells through PI3K/Akt and XIAP pathways.

Authors:  Jia-He Wang; Jian-Fei Nao; Meng Zhang; Ping He
Journal:  Tumour Biol       Date:  2014-08-29

9.  Influence of the toothpaste with brazilian ethanol extract propolis on the oral cavity health.

Authors:  Dariusz Skaba; Tadeusz Morawiec; Marta Tanasiewicz; Anna Mertas; Elżbieta Bobela; Ewelina Szliszka; Małgorzata Skucha-Nowak; Monika Dawiec; Rindai Yamamoto; Shinobu Ishiai; Yuki Makita; Małgorzata Redzynia; Beata Janoszka; Iwona Niedzielska; Wojciech Król
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-04       Impact factor: 2.629

10.  Influence of propolis on hygiene, gingival condition, and oral microflora in patients with cleft lip and palate treated with fixed orthodontic appliances.

Authors:  Agnieszka Machorowska-Pieniążek; Tadeusz Morawiec; Anna Mertas; Marta Tanasiewicz; Arkadiusz Dziedzic; Wojciech Król
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.